Pfizer

Big Pharma Is Raising The Price Of Thousands Of Drugs Despite Trump’s Best Efforts

7:59 PM 07/15/2018<p>President Donald Trump’s administration is pressuring major pharmaceutical companies to lower their prices, but they aren’t …

Conservative View

FDA OKs expanded use for prostate cancer med Xtandi

Pfizer (PFE +0.1%) and collaboration partner Astellas Pharma (OTCPK:ALPMF) announce that the FDA has approved the use of XTANDI (enzalutamide) to …

Business

Pfizer’s Hospira Site in India Lands Another FDA Form 483

In a 32-page US Food and Drug Administration (FDA) Form 483, 11 citations revealed manufacturing and quality control issues at the Hospira Healthcare …

FDA

Generic Viagra floods the market. Here’s how Pfizer is reacting

Until Viagra hit the scene in the late '90s, treatment options for erectile dysfunction were limited.<p>“The thing that made Viagra so wonderful was the only thing before that was a drug called Caverject,” said former Pfizer attorney Kent Bernard. “Caverject needed to be injected into your penis about …

Pharma

How Pfizer-Trump Game Of Chicken Could Play Out For Drug Prices

<b>Pfizer</b> (PFE) and President Donald Trump are playing a game of chicken over drug price increases — and a number of other pharmaceutical companies …

Business

Did Pfizer Blink, And What Will Pharma Do Now?

After the 2017 Forbes Healthcare Summit last December, I wrote that pharmaceutical companies were on borrowed time when it came to further price increases. This past Tuesday, Pfizer confirmed that time had run out for raising prices without blow-back. Given the volume of dialogue about drug price …

Donald Trump

Pfizer boss humbled after ‘man to man’ talk with Donald Trump | Financial Times

When Ian Read decided to hoist the price of 100 products earlier this month, the Pfizer chief executive was unprepared for the fallout.<p>On Monday …

Donald Trump

STAT Plus: How Pfizer’s CEO flew under the political radar with price hikes — until he tangled with Trump

As the CEO of Pfizer, the world’s largest drug maker, Ian Read followed a years-long pricing strategy that reaped billions for his company. It was …

Bioethics

Pfizer Is Not An All-Powerful Price-Hiker

For a supposedly greedy, all-powerful, price-hiking Big Pharma megacap, Pfizer's (PFE) stock sure isn't doing too well over the long term. There …

Business

Pfizer rolls back drug price hikes after pressure from Trump

Pfizer

Pfizer stops production at Tamil Nadu plant after 11 USFDA observations

Firm says it is disappointed with the outcome of the inspection

Tamil Nadu

Dividend-Rich Dow Jones Stock Pfizer Shows Near-4% Yield; New Buy Point Emerges

Amid pressure from President Trump, Dividend Leader List member <b>Pfizer</b> (PFE) announced it would defer drug price increases and await the President's …

Investing

Can Mylan dodge Pfizer's Remicade woes with a low-priced Neulasta copy?

Mylan has disclosed the wholesale price it will put on its biosimilar of Amgen’s Neulasta—and it’s one that has the potential to transform the …

Pharma

As Catchmark Timber Tr (CTT) Market Valuation Declined, Shareholder Secor Capital Advisors LP Has Raised Its Stake; Pfizer (PFE) Holder Hm Payson & Company Lowered Stake by $344,575

<b>July 12, 2018 - By Margaret Staats</b><p>Hm Payson & Company decreased its stake in Pfizer Inc (PFE) by 0.66% based on its latest 2018Q1 regulatory filing …

Cannabis Industry

Pfizer's China Exposure Could Dampen Its Reshuffle Hopes

The success of Pfizer Inc.'s (PFE) reshuffle could depend on a country that has fueled its growth thus far: China.<p>Pfizer Inc. declined 0.4% to $37.21 …

Jim Cramer

Final Trade: CGC, DAL & more

The "Fast Money" traders share their final trades of the day, including Canopy Growth, General Electric, Pfizer and Delta Airlines.

General Electric

Trump got Pfizer to reverse its drug price hikes — but he gave up some big concessions

He got himself into making a promise it’s now up to him to keep.<p>President Donald Trump declared war and then victory with drug maker Pfizer within a matter of hours this week, claiming to have successfully convinced the pharmaceutical company to roll back drug price increases.<p>And he did — sort of. …

U.S. Politics

Pfizer's Reorganization Into 3 Businesses Seeks to Unlock Value

Pfizer Inc. (<b>PFE</b> - <i>Get Report</i>) retreated 0.2% after market close, after announcing it would break into three, more specialized businesses focusing on …

Fortune 500

Pfizer VP says Gardasil is bad – I bow to his superior knowledge

I know that I'm going to make my loyal readers all have strokes by telling all of you that an anti-vaccine website gets all the facts wrong about the …

Nobel Prize

If You're Retired, Consider Buying These 3 Stocks

These stocks check off all the boxes for retired investors.<p>If you're retired, you probably already know that investing primarily in bonds isn't …

Investing

Drug giant Pfizer to reorganize into three businesses

Drug giant Pfizer on Wednesday said it plans to split into three businesses: a science-based "innovative medicines" business, an off-patent branded …

Pfizer

Pfizer Reorganization Could Set the Stage for Full-Blown Spinoff

The proposed reorganization of the 169-year-old Pfizer Inc.'s (PFE) business separating a new major unit covering more innovative drugs including …

Selling

Pfizer separates consumer health unit in business rejig

(Reuters) - Pfizer Inc announced plans on Wednesday to reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year.<p>The company said it is still looking for options for the lower-margin, non-core consumer healthcare …

Business

REPLAY: Jim Cramer on Tariffs, Oil Prices and Pfizer's Reorganization

Let's go over the market on Wednesday.<p>Jul 11, 2018 3:52 PM EDT<p>Investment capital is flowing into gold stocks and Frank Holmes, CEO of U.S. Investors, …

Jim Cramer

Drug Supply Chain Feels the Trump Effect

A small gesture on pricing is likely to have a big impact on the prescription drug industry.<p>On Tuesday evening, Pfizersaid it would defer planned price increases on about 10% of its prescription medicines after President Donald Trump spoke with CEO Ian Read and criticized the company on Twitter. …

Pharma

4 Things You Need to Know About Pfizer's Restructuring Plans

What's behind the big pharma company's big reorg?<p><b>Pfizer</b> (NYSE:PFE) was in the news Wednesday for a second day in a row. On Tuesday, the company …

Johnson & Johnson

Pfizer Inc to reorganize company into three units

<i>0</i><p>Recent Alerts<p>Sign up to create alerts for Instruments, Economic Events and content by followed authors<p>Free Sign Up<p>Already have an account? Sign …

Financial Markets

Pfizer Caving to Trump Has Wall Street Asking Who's Next

Pfizer’s decision to delay planned drug price hikes after President Trump attacked the company on Twitter may cause another shakeout throughout the …

Health Care

Cramer sees Pfizer's reorganization as a 'prelude' to a spin off of its consumer health-care business

Pfizer's announced reorganization could lead to an eventual spin off of its consumer health-care business, CNBC's Jim Cramer said on Wednesday.<p>The …

Health Care

Pfizer will reorganize into three internal divisions

Pfizer Inc. is organizing itself into three different businesses as it continues to mull the future of its over-the-counter medicines unit.<p>The …

Health Care